A Clinical Study of iNSC Intervent Cerebral Hemorrhagic Stroke

General Information

Summary This is a single centre, single arm, open-label study, to investigate the safety and efficacy of induction of neural stem cells transplantation in the brain.
Clinical trials phase Other
Start date (estimated) 2019-03-01
End date (estimated) 2019-03-31
Clinical feature
Label Ischemic Stroke
Link http://purl.obolibrary.org/obo/NCIT_C95802
Description An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.

Administrative Information

NCT number NCT03725865
ICTRP weblink https://trialsearch.who.int/Trial2.aspx?TrialID=NCT03725865
Other study identifiers
Name iNSC-81NK-01
Source weblink https://clinicaltrials.gov/ct2/show/NCT03725865
Public contact
Email alife
Public email allife@allifetech.com
First name allife@allifetech.com
City Beijing
Sponsors Allife Medical Science and Technology Co., Ltd.


Which differentiated cell type is used
Label neural stem cell
Link http://purl.obolibrary.org/obo/CL_0000047
Description An undifferentiated neural cell that originates from the neuroectoderm and has the capacity both to perpetually self-renew without differentiating and to generate multiple central nervous system neuronal and glial cell types.


Recruitment Status Unknown Status
Estimated number of participants 12